CYP3A4 and preeclampsia: Moreover, we did not quantify other endogenous factors (such as inflammatory cytokines) or concomitant medication use (such as nifedipine or labetalol) at the time of blood sampling that could influence CYP3A activity and impact 4β-OH-CHO associations with PRHs in patients with preeclampsia.